Abstract:Organ transplantation-Sichuan Youth Science and Technology Innovation Research Team. Background: Although islet xenotransplantation has been proven to be a promising strategy for treatment of type 1 diabetes, it’s application in clinical setting would have to overcome acute cellular rejection and challenging species barrier. The aim of this study was to determine the role of Foxp3+ regulatory T cells (Treg) in anti-CD45RB induced dominant and specific tolerance to human islet cells in mice. Methods: One thousand and five hundred IEQ human islets were isolated from deceased donors and transplanted under the kidney capsule of B6 diabetic mice, B6µMT-/- mice and thymectomized µMT-/- mice. The recipients were then temporarily treated with low dose anti-CD45RB. CD4+Foxp3+Tregs were identified in the blood, spleen, draining lymph nodes and within the graft of tolerant and rejecting mice by FCM and immunohistochemistry. Additional anti-CD25 mAb was applied in the tolerant B6µMT-/-mice, which received another human islets simultaneously. The CD4+CD25+ Tregs sorted from the tolerant mice were adoptively transferred to diabetic Scid mice which were grafted with another human islets to assess the suppressive function. Results: In vitro, CD4+CD25-Foxp3-T cells which were activated with anti-CD3/anti-CD28 beads and cultured with anti-CD45RB demonstrated significant increase in Foxp3+ expression. In vivo, an increase of Foxp3+ T cells was observed in treated mice and more significant increase in tolerant mice, compared with a negligible increase in rejected mice. Anti-CD45RB alone allowed indefinite graft survival in 26.6% of B6 mice and 88.9% in µMT-/- mice, whereas none of xenografts were accepted in these mice treated simultaneously with anti-CD25. µMT-/-mice which were thymectomized and treated by anti-CD45 yielded 100% of grafts with long-term survival, which indicated that the transplant tolerance was thymus-derived Tregs independent. Moreover, the µMT-/-mice which tolerated to the first human islets accepted the re-transplanted second party of islets from another human, whereas the tolerance was hampered by anti-CD25 treatment. Adoptive cell transfer model showed the CD4+CD25+ Tregs from the mice tolerant to the first human islets prolonged survival of the second human islets, compared to natural Tregs (p < 0.05). Conclusions: These data suggest that anti-CD45RB-induced tolerance in islet xenotransplantation is mediated by Tregs expansion. These tolerant Tregs had the potent capacity to transfer dominant and species-specific tolerance. The National Natural Science Foundation of China (No. 81172832, 81771723). Sichuan Youth Science and Technology Foundation (2013JQ0020). Special Program for Sichuan Youth Science and Technology Innovation Research Team (2014TD0010).

P17.09: CD27-Expressing Xenoantigen-Expanded Human Regulatory T Cells Are Efficient in Suppressing Xenogeneic Immune Response

CD27-Expressing Xenoantigen-Expanded Human Regulatory T Cells Are Efficient in Suppressing Xenogeneic Immune Response

Enhanced suppression of the xenogeneic T-cell response in vitro by xenoantigen stimulated and expanded regulatory T cells

Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model

Large-scale in vitro expansion of human regulatory T cells with potent xenoantigen-specific suppression

Gut Microbes Enlarged the Protective Effect of Transplanted Regulatory B Cells on Rejection of Cardiac Allografts.

Porcine-Stimulated Human Tr1 Cells Showed Enhanced Suppression in Xenoantigen Stimulation Response

Decreased percentages of regulatory T cells are necessary to activate Th1-Th17-Th22 responses during acute rejection of the peripheral nerve xenotransplantation in mice

Engineered Regulatory T Cells Prevent Graft-Versus-host Disease While Sparing the Graft-Versus-leukemia Effect after Bone Marrow Transplantation.

Antigen-Dependent Suppression of Alloresponses by Foxp3-Induced Regulatory T Cells in Transplantation

Induced regulatory T cells modified by knocking down T-bet in combination with ectopic expression of inhibitory cytokines effectively protect graft-versus-host disease.

Transfer of Regulatory T Cells Generated Ex Vivo Modifies Graft Rejection Through Induction of Tolerogenic CD4+CD25+ Cells in the Recipient

Ex Vivo Expanded Human Non-Cytotoxic CD8+CD45RClow/− Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized Mice

IN VIVO ANTI-CD45RB ANTIBODY-INDUCED REGULATORY T CELLS DEMONSTRATE SPECIES-SPECIFIC TOLERANCE TO DISCORDANT HUMAN XENOGENIC ISLETS

T regulatory cells as an immunotherapy for transplantation.

Alternative Immunomodulatory Strategies for Xenotransplantation: CD80/CD86-CTLA4 Pathway-Modified Immature Dendritic Cells Promote Xenograft Survival.

T Regulatory Cells As an Immunotherapy for Transplantation

Efficient And Selective Prevention Of Graft-Versus-Host Disease By Ag-Specific Induced Regulatory T Cells In Mice

Ex Vivo Expansion of Human Tregs Specific for Alloantigens Presented Directly or Indirectly.

Human-engineered Treg-like cells suppress FOXP3-deficient T cells but preserve adaptive immune responses in vivo

Prolongation of corneal xenotransplant survival by T-cell vaccination-induced T-regulatory cells.